share_log

Insiders At Cardinal Health Sold US$18m In Stock, Alluding To Potential Weakness

Insiders At Cardinal Health Sold US$18m In Stock, Alluding To Potential Weakness

卡地納健康內部人士出售了1800萬美元的股票,暗示可能存在的弱點
Simply Wall St ·  2024/11/30 03:18

The fact that multiple Cardinal Health, Inc. (NYSE:CAH) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When analyzing insider transactions, it is usually more valuable to know whether insiders are buying versus knowing if they are selling, as the latter sends an ambiguous message. However, when multiple insiders sell stock over a specific duration, shareholders should take notice as that could possibly be a red flag.

過去一年多位卡地納健康(紐交所:CAH)內部人士出售了大量股票,這可能引起投資者的關注。 在分析內部交易時,了解內部人士是買入還是賣出通常更加重要,因爲後者傳達的信息很模糊。然而,當多位內部人士在特定時間段內出售股票時,股東應該引起注意,因爲這可能是一個警示信號。

While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.

雖然我們絕不會建議投資者僅僅依據公司的董事們所做的事情來做決定,但我們認爲完全忽視內部交易是愚蠢的。

Cardinal Health Insider Transactions Over The Last Year

過去一年裏,卡地納健康公司內部交易情況

Over the last year, we can see that the biggest insider sale was by the CEO & Director, Jason Hollar, for US$8.0m worth of shares, at about US$109 per share. That means that even when the share price was below the current price of US$123, an insider wanted to cash in some shares. As a general rule we consider it to be discouraging when insiders are selling below the current price, because it suggests they were happy with a lower valuation. While insider selling is not a positive sign, we can't be sure if it does mean insiders think the shares are fully valued, so it's only a weak sign. This single sale was just 46% of Jason Hollar's stake.

在過去一年中,我們可以看到最大的一筆內部出售是由首席執行官兼董事Jason Hollar出售的,價值800萬美元的股票,售價約爲每股109美元。這意味着即使在股價低於當前的123美元時,一位內部人士也想兌現一些股票。一般來說,我們認爲內部人士在低於當前價格時出售是令人沮喪的,因爲這表明他們對較低的估值感到滿意。儘管內部人士的賣出不是一個積極的信號,我們不能確定這是否意味着內部人士認爲股票價值已完全體現,因此這只是一個弱信號。這次出售僅佔Jason Hollar股份的46%。

Cardinal Health insiders didn't buy any shares over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

過去一年卡地納健康的內部人士沒有購買任何股票。下面的圖表顯示了過去一年內部交易(由公司和個人進行)。如果您想準確了解誰賣出、賣出多少以及何時賣出,只需點擊下面的圖表!

big
NYSE:CAH Insider Trading Volume November 29th 2024
紐交所: 卡地納健康內部交易量2024年11月29日

If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: Most of them are flying under the radar).

如果你喜歡買入內部人士正在買入而不是賣出的股票,那麼你可能會喜歡這份免費的公司名單。(提示:他們中的大多數正處於雷達之外)。

Cardinal Health Insiders Are Selling The Stock

卡地納健康內部人士正在出售該股

The last quarter saw substantial insider selling of Cardinal Health shares. In total, Senior VP & Chief Accounting Officer Mary Scherer sold US$433k worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain.

上個季度卡地納健康的內部人士大規模拋售股票。總的來說,高級副總裁兼首席會計官瑪麗·謝雷在此期間出售了價值43.3萬美元的股票,我們沒有記錄到任何購買。鑑於此,很難說所有內部人士都認爲這些股票是個好交易。

Does Cardinal Health Boast High Insider Ownership?

卡地納健康是否擁有較高的內部所有權?

I like to look at how many shares insiders own in a company, to help inform my view of how aligned they are with insiders. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. Cardinal Health insiders own 0.4% of the company, currently worth about US$109m based on the recent share price. This kind of significant ownership by insiders does generally increase the chance that the company is run in the interest of all shareholders.

我喜歡查看公司內部人士擁有多少股票,以幫助判斷他們與內部人士的利益是否一致。通常,內部人士的持股比例越高,內部人士就越有可能被激勵爲公司的長期發展而努力。卡地納健康的內部人士擁有0.4%的公司股份,按照近期股價計算,當前價值約爲10900萬美元。內部人士的這種重大持股一般會增加公司以所有股東利益爲目標運營的可能性。

So What Does This Data Suggest About Cardinal Health Insiders?

那麼,這些數據對卡地納健康的內部人員有何啓示?

An insider sold Cardinal Health shares recently, but they didn't buy any. Looking to the last twelve months, our data doesn't show any insider buying. But it is good to see that Cardinal Health is growing earnings. It is good to see high insider ownership, but the insider selling leaves us cautious. In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Cardinal Health. Every company has risks, and we've spotted 1 warning sign for Cardinal Health you should know about.

最近有一位內部人士出售了卡地納健康的股票,但他們沒有買入任何股票。回顧過去十二個月,我們的數據沒有顯示任何內部人士的買入。但看到卡地納健康的盈利增長是件好事。看到內部人士的持股比例很高也不錯,但內部人士的賣出讓我們感到謹慎。除了了解內部交易情況外,識別卡地納健康面臨的風險也很重要。每家公司都有風險,我們發現了一個需要你知道的卡地納健康的警示信號。

But note: Cardinal Health may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

但請注意:卡地納健康可能不是最值得買入的股票。因此,可以看看這份免費名單,裏面有一些高ROE和低負債的有趣公司。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

在本文中,內部人士是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall ST的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall ST在提到的任何股票中均沒有持倉。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論